Testing for human papillomavirus in BRAF inhibitor‐associated verrucous keratoses

E-ISSN： 1600-0560|42|1|73-75

ISSN： 0303-6987

Source： JOURNAL OF CUTANEOUS PATHOLOGY, Vol.42, Iss.1, 2015-01, pp. : 73-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Case of Verrucous Carcinoma Associated with Human Papillomavirus Type 16 DNA

THE JOURNAL OF DERMATOLOGY, Vol. 20, Iss. 8, 1993-08 ,pp. : 483-488

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primary human papillomavirus testing

CANCER CYTOPATHOLOGY, Vol. 123, Iss. 5, 2015-05 ,pp. : 269-270

John Wiley & Sons Inc

Access to resources Recommend Favorite

Spindle cell squamous cell carcinoma arising from verrucous hyperplasia during BRAF inhibitor therapy for melanoma

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, Vol. 13, Iss. 4, 2015-04 ,pp. : 326-328

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acanthoma planoepitheliale hyperkeratoticum, lesions associated with BRAF inhibitor in metastatic melanoma

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 32, Iss. 2, 2018-02 ,pp. : e83-e84

John Wiley & Sons Inc

Access to resources Recommend Favorite

Laboratory and clinical aspects of human papillomavirus testing

By Chan Paul K. S. Picconi María Alejandra Cheung Tak Hong Giovannelli Lucia Park Jong Sup

Critical Reviews in Clinical Laboratory Sciences, Vol. 49, Iss. 4, 2012-08 ,pp. : 117-136

Informa Healthcare

Access to resources Recommend Favorite